Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Project Information

TT4CL

Grant agreement ID: 815622

DOI

10.3030/815622

Project closed

EC signature date 30 April 2019

Start date 1 May 2019

End date 31 July 2024

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

No data

EU contribution

€ 3 753 135,56

Coordinated by

ST GEORGE'S HOSPITAL MEDICAL SCHOOL
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (1)

Set up of Website

Report on the set-up and function of the project website.

Publications

Peer reviewed articles (3)

Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis – challenges and opportunities

Author(s): Katrien Van Bocxlaer, Simon L. Croft
Published in: RSC Medicinal Chemistry, Issue 12/4, 2021, Page(s) 472-482, ISSN 2632-8682
Publisher: Royal Society Chemistry
DOI: 10.1039/d0md00343c

Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis

Author(s): Gert-Jan Wijnant, Franck Dumetz, Laura Dirkx, Dimitri Bulté, Bart Cuypers, Katrien Van Bocxlaer, Sarah Hendrickx
Published in: Frontiers in Tropical Diseases, Issue 3, 2022, ISSN 2673-7515
Publisher: Frontiers
DOI: 10.3389/fitd.2022.837460

Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis

Author(s): Katrien Van Bocxlaer, Jodie Dixon, Johannes J Platteeuw, Dennie Van Den Heuvel, Kerri-Nicola Mcarthur, Andy Harris, Mo Alavijeh, Simon L Croft, Vanessa Yardley
Published in: Journal of Antimicrobial Chemotherapy, Issue 78, 2023, Page(s) 1723-1731, ISSN 0305-7453
Publisher: Oxford University Press
DOI: 10.1093/jac/dkad162

Intellectual Property Rights

Patent (4)

TABLET DOSAGE FORMULATIONS OF OLEYL PHOSPHOCHOLINE

Application/Publication number: 20 20060324
Date: 2020-04-10
Applicant(s): OBLITA THERAPEUTICS

TABLET DOSAGE FORMULATIONS OF OLEYL PHOSPHOCHOLINE

Application/Publication number: 20 20060324
Date: 2020-04-10
Applicant(s): OBLITA THERAPEUTICS

OLEYL PHOSPHOCHOLINE CONTAINING GRANULATES

Application/Publication number: 20 20078476
Date: 2020-10-09
Applicant(s): OBLITA THERAPEUTICS

OLEYL PHOSPHOCHOLINE CONTAINING GRANULATES

Application/Publication number: 20 20078476
Date: 2020-10-09
Applicant(s): OBLITA THERAPEUTICS